Skip to main content

Table 1 Patient characteristics

From: Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis – a prospective cohort study

Analysis

All (n = 121)

Responders (n = 73)

Non-responders (n = 48)

P-value

Age, mean (years)

60.5 ± 14.0

58.2 ± 14.8

64.0 ± 11.9

0.023

Sex (M/F)

31/90

19/54

12/36

0.899

Current smoking

19/121 (16%)

11/73 (15%)

8/48 (17%)

0.813

RA duration, median (years)

10 (0 to 60)

11 (0 to 60)

8 (0 to 40)

0.60

Weight, mean (kg)

73.1 ± 16.4

72.1 ± 16.2

74.8 ± 16.8

0.375

HAQ index, mean

1.07 ± 0.64

1.08 ± 0.67

1.05 ± 0.60

0.791

DAS28 index, mean

4.40 ± 1.20

4.53 ± 1.22

4.21 ± 1.52

0.145

CRP, median (mg/L)

10.8 (0.1 to 159)

12.9 (0.2 to 159)

9.4 (0.7 to 119)

0.14

Larsen-Dale index, mean

1.50 ± 1.3

1.2 ± 1.06

1.9 ± 1.45

0.002

Synovial fluid, median (ml)

10 (0 to 105)

8 (0 to 105)

16.5 (0 to 75)

0.006

  1. Mean ± SD, Median (range), Bold figures: P <0.003. CRP, C-reactive protein; DAS28, disease activity score in 28 joints; F, female; HAQ, Health Assessment Questionnaire; M, male; n, number; RA, rheumatoid arthritis; SD, standard deviation.